Potential DMD Gene Therapy, SGT-001, Shows Signs of Microdystrophin Production in Muscles, Early Trial Data Show
Duchenne Muscular Dystrophy - Capricor
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) - Neuromuscular Disorders
Frontiers | Combined Therapies for Duchenne Muscular Dystrophy to Optimize Treatment Efficacy | Genetics
Duchenne Muscular Dystrophy » Powell Center for Rare Disease Research and Therapy » College of Medicine » University of Florida
Muscular Dystrophy Association Celebrates FDA Approval of Viltolarsen for Treatment of Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping | Muscular Dystrophy Association
Ongoing clinical trials 1 and approval status of therapeutic approaches... | Download Table
Enhanced CRISPR-Cas9 correction of Duchenne muscular dystrophy in mice by a self-complementary AAV delivery system
VISION-DMD – Designed to ensure a timely & cost-effective drug development for Duchenne muscular dystrophy
MDA Celebrates FDA Approval of Amondys 45 for Treatment of DMD Amenable to Exon 45 Skipping | Muscular Dystrophy Association
Duchenne Muscular Dystrophy (DMD): Clinical Trial OF Systemic Delivery Of Micro-Dystrophin Gene Therapy In Children With DMD Shows Positive Results - Thailand Medical News
Clinical Trial Alert: Early Phase Study of SRP-9001 in Boys with DMD - Muscular Dystrophy Association
Exondys 51 (eteplirsen) for the Treatment of Duchenne Muscular Dystrophy ( DMD) - Clinical Trials Arena
Muscular Dystrophy Treatment Market – Molecular therapy segment is expected to generate larger revenue with higher efficiency in clinical trials | Medgadget
Duchenne Muscular Dystrophy - Practical Neurology
HTAQ Summer 2017 Duchenne Muscular Dystrophy New and Revitalized Drugs Bring Hope to Patients | Xcenda